Shares of ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) rose 9.3% on Friday . The stock traded as high as $0.45 and last traded at $0.45. Approximately 285,512 shares traded hands during mid-day trading, an increase of 1,305% from the average daily volume of 20,327 shares. The stock had previously closed at $0.41.
ImmunoPrecise Antibodies Trading Up 9.3 %
The business has a fifty day moving average price of $0.42 and a 200-day moving average price of $0.66.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Featured Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- ETF Screener: Uses and Step-by-Step Guide
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- What Are Trending Stocks? Trending Stocks Explained
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
